Renal Toxicity After Radionuclide Therapy
Journal Title: Nuclear Medicine Seminars - Year 2019, Vol 5, Issue 3
Abstract
With the introduction of radionuclide therapies, the probability of toxicity has increased in critical organs such as kidney and bone marrow. Although these toxicity rates are relatively low in targeted therapies such as radionuclide therapy, a number of organs, especially the kidneys, are affected by radiation. Radionuclide therapies that led to the major risk for renal toxicity are neuroendocrine tumor treatment with beta-emitting radioisotopes (Lu-177 and Y-90) labeled with [DOTA0, Tyr3]-octreotate (DOTATATE), and prostate cancer treatment with alpha or beta emitters, such as Lu-177 or Ac-225, labeled with prostate specific membrane antigen. The intense uptake and prolonged retention of these radioactive molecules in the kidneys raise concerns about the potential toxicity of kidneys by radiation that puts therapeutic efficacy at risk. In this review, nephrotoxicity resulting from radionuclide therapy, particularly Lu-177 and Y-90, and therapeutic options to reduce the toxicity are discussed.
Authors and Affiliations
Nalan Alan Selçuk, Türkay Toklu
Keywords
Related Articles
- EP ID EP685341
- DOI 10.4274/nts.galenos.2019.0029
- Views 167
- Downloads 0
F-18 FDG PET/CT Practice Guideline in Oncology: Assesment of Treatment Response
Assessing response to treatment is an important parameter in oncology practice and there is a growing body of evidence for use of F-18 fludeoxyglucose (FDG) positron emission tomography/computerized tomography (PET/CT) t...
Radionuclide Treatment in Pain Palliation
Skeletal system is the most common metastasis site in patients with advanced cancer. Pain is an important health problem in patients with bone metastasis. Bone seeking radionuclides to treat bone pain due to bone metasta...
Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals
As it is known, magistral radiopharmaceuticals are suitable for only in house use and are prepared, produced and supplied with a medical prescription for a certain patient in good laboratory practice (GLP) standard by a...
Differentiated Thyroid Carcinoma in Pediatric Age Group/Differences in Diagnosis, Therapy and Follow-up
Differentiated thyroid cancer in childhood is rare. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable...
Radionuclide Methods for Pain Palliation
Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and results in serious symptoms and complications such as bone pain, pathological fractures, spinal cord compression, and malignant hype...